Please login to the form below

Not currently logged in
Email:
Password:

Rubius Therapeutics poaches Novartis’ Spencer Fisk

He joins the US biotech as its senior VP manufacturing

Novartis’ former vice president and global head of cell and gene technical development and manufacturing Spencer Fisk has decided to join Rubius Therapeutics.

He takes up its senior vice president of manufacturing role as the company is looking to expand its manufacturing and development organisations.

Torben Straight Nissen, president of Rubius Therapeutics, said: “Spencer’s expertise and decades of experience in process development and manufacturing will be invaluable and I look forward to working closely together as we continue to deliver on the promise of the next generation of cellular therapies for patients in need.”

Prior to his new role, Fisk spent the last six years at Novartis where he led the CMC development-manufacturing organisation to deliver the CAR-T portfolio of the company.

He has also held a series of leadership positions for both Merck and Schering Plough.

Fish said: “Rubius is developing an entirely new class of ready-to-use cell therapeutics to treat cancer, autoimmune disorders and rare diseases.

“I look forward to leveraging the expertise i've gained while working with larger pharmaceutical companies to help Rubius take its extraordinary RTC pipeline into the clinic.”

6th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...

Infographics